Simone Cesaro, Director Pediatric Hematology Oncology Unit at Integrated University Hospital of Verona and Founding Board Member at European Conference on Infections on Leukemia and Stem Cell Transplantations, shared a post on LinkedIn:
“Fanconi anemia is a rare genetic syndromic disease associated with shorter life-expectancy. Hematopoietic stem cell transplantation is useful to treat severe cytopenia or clonal evolution but it does not impact on non-haematological phenotype, especially on the predisposition to develop secondary solid tumors. A study from the Italian registry of Fanconi Anemia. Fanconi anemia hematopoietic stem cell transplantation secondary solid tumors.”